Spin-out of Imperial College London developing ground-breaking vector and pest control solutions for a healthier and more sustainable world
Biocentis has raised $12.8M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Biocentis's investors include Wellcome Trust, Algebris Investments, Novaterra, Grantham Foundation, Corbites.
Biocentis is headquartered in London, United Kingdom.
Spin-out of Imperial College London developing ground-breaking vector and pest control solutions for a healthier and more sustainable world
Biocentis is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biocentis — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/biocentis. Accessed September 16, 2026.
VCBacked. (2025). Biocentis — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/biocentis
{{cite web |title=Biocentis — Funding & Investors |url=https://www.vcbacked.co/company/biocentis |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated